New tools for evaluating protein tyrosine sulphation: Tyrosyl Protein Sulphotransferases (TPSTs) are novel targets for RAF protein kinase inhibitors. Read more about New tools for evaluating protein tyrosine sulphation: Tyrosyl Protein Sulphotransferases (TPSTs) are novel targets for RAF protein kinase inhibitors.
New tools for carbohydrate sulphation analysis: Heparan Sulphate 2- O -sulphotransferase (HS2ST) is a target for small molecule protein kinase inhibitors. Read more about New tools for carbohydrate sulphation analysis: Heparan Sulphate 2- O -sulphotransferase (HS2ST) is a target for small molecule protein kinase inhibitors.
Identification of Rpl29 as a major substrate of the lysine methyltransferase Set7/9. Read more about Identification of Rpl29 as a major substrate of the lysine methyltransferase Set7/9.
SATurn: A modular bioinformatics framework for the design of robust maintainable web-based and standalone applications. Read more about SATurn: A modular bioinformatics framework for the design of robust maintainable web-based and standalone applications.
A TFEB nuclear export signal integrates amino acid supply and glucose availability. Read more about A TFEB nuclear export signal integrates amino acid supply and glucose availability.
Chemoproteomics and Chemical Probes for Target Discovery. Read more about Chemoproteomics and Chemical Probes for Target Discovery.
Small molecule inhibitors reveal an indispensable scaffolding role of RIPK2 in NOD2 signaling. Read more about Small molecule inhibitors reveal an indispensable scaffolding role of RIPK2 in NOD2 signaling.
Zinc(II) binding on human wild-type ISCU and Met140 variants modulates NFS1 desulfurase activity. Read more about Zinc(II) binding on human wild-type ISCU and Met140 variants modulates NFS1 desulfurase activity.
Targeting Pim Kinases and DAPK3 to Control Hypertension. Read more about Targeting Pim Kinases and DAPK3 to Control Hypertension.
LLY-283, a Potent and Selective Inhibitor of Arginine Methyltransferase 5, PRMT5, with Antitumor Activity. Read more about LLY-283, a Potent and Selective Inhibitor of Arginine Methyltransferase 5, PRMT5, with Antitumor Activity.
